US Patent Issued to The University of Cincinnati, The General Hospital on July 1 for "Modulating phosphatase activity in cardiac cells" (New York, Ohio, Massachusetts Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,353, issued on July 1, was assigned to The University of Cincinnati (Cincinnati) and The General Hospital Corp. (Boston).

"Modulating phosphatase activity in cardiac cells" was invented by Roger J. Hajjar (New York), Federica Del Monte (Boston) and Evangelia Kranias (Cincinnati).

According to the abstract* released by the U.S. Patent & Trademark Office: "Expression of a phosphatase inhibitor in heart cells can be used to treat cardiac disorders, e.g., heart failure. Decreasing phosphatase activity can improve Beta-adrenergic responsiveness."

The patent was filed on April 11, 2019, under Application No. 16/381,781.

*For further information, including images, charts and tables, pl...